Provided by Tiger Trade Technology Pte. Ltd.

AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF

27.00
+0.30111.13%
Volume:392
Turnover:10.60K
Market Cap:5.40M
PE:- -
High:27.00
Open:27.00
Low:27.00
Close:26.70
52wk High:27.94
52wk Low:22.63
Shares:200.00K
Float Shares:200.00K
Volume Ratio:0.61
T/O Rate:0.20%
Dividend:0.41
Dividend Rate:1.53%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Eli Lilly: Under Terms of Agreement, Lilly Will Acquire Merida and Pay up to $2.875 Bln in Cash

THOMSON REUTERS
·
Aug 31

Lilly to Acquire Merida Biosciences to Advance Treatments for Serious Autoimmune and Allergic Diseases

THOMSON REUTERS
·
Aug 31

Eli Lilly - Deal Expected to Close in Q4 2026 Subject to Regulatory Approvals

THOMSON REUTERS
·
Aug 31

ASX listed pharma boosted by weight loss drugs

Morning Star AU
·
Aug 31

Pharma Industry Stares Down Biggest Patent Cliff in Decades

Dow Jones
·
Aug 29

India's GLP-1 Weight-Loss Drugs Stall at $14 Monthly Despite High Diabetes Rates

Deep News
·
Aug 29

Eli Lilly (LLY) Wins FDA Approval For Mounjaro Heart Risk Reduction

Simply Wall St.
·
Aug 29

Novo Nordisk A/S Series B Stock Rises Friday

Dow Jones
·
Aug 29

Sector Update: Health Care Stocks Mixed Pre-Bell Friday

MT Newswires Live
·
Aug 28

FDA Approves Lilly's Mounjaro to Cut Cardiovascular Event Risk in High-Risk Type 2 Diabetes Adults

Reuters
·
Aug 28

FDA Approves Lilly's Mounjaro (Tirzepatide) to Reduce Cardiovascular Risk in Adults with Type 2 Diabetes

THOMSON REUTERS
·
Aug 28

Novo Nordisk Share Price Already Reflects Plenty of Pessimism

Dow Jones
·
Aug 28

Dow Jones Top Company Headlines at 11 PM ET: Judge Rules Trump Administration's Blacklisting of Anthropic was Unlawful | Nvidia ...

Dow Jones
·
Aug 28

Eli Lilly (LLY) Says Zepbound Cuts Healthcare Costs For Adults Over 55

Simply Wall St.
·
Aug 27

Novo Nordisk Shares Drop as Bank Downgrade Reflects Growth Concerns

Dow Jones
·
Aug 27

Sector Update: Healthcare

MT Newswires Live
·
Aug 27

Scholar Rock to Present at Cantor Global Healthcare Conference Fireside Chat

Reuters
·
Aug 27

Novo Nordisk says China’s NMPA accepted application for marketing of Wegovy

TIPRANKS
·
Aug 27

Ozempic Maker Novo Nordisk Downgraded to Sell After 70% Stock-Price Dive from Peak

Dow Jones
·
Aug 27

Novo Nordisk (0QIU) was downgraded to a Sell Rating at Deutsche Bank

TIPRANKS
·
Aug 27